{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:41:21Z","timestamp":1790206881103,"version":"4.1.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.transproceed.2010.05.127","type":"journal-article","created":{"date-parts":[[2010,10,22]],"date-time":"2010-10-22T10:29:48Z","timestamp":1287743388000},"page":"3167-3168","source":"Crossref","is-referenced-by-count":50,"title":["Efficacy and Safety of Entecavir and\/or Tenofovir for Prophylaxis and Treatment of Hepatitis B Recurrence Post\u2013Liver Transplant"],"prefix":"10.1016","volume":"42","author":[{"given":"M.","family":"Jim\u00e9nez-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.B.","family":"S\u00e1ez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mongil Poce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Lozano-Rey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"de la Cruz-Lombardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Rodrigo-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2010.05.127_bib1","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1365-2036.2006.02855.x","article-title":"Review article: hepatitis B and liver transplantation","volume":"23","author":"Mutimer","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.transproceed.2010.05.127_bib2","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/lt.20492","article-title":"Management of the hepatitis B virus in the liver transplantation setting: a European and an American perpective","volume":"11","author":"Terrault","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2010.05.127_bib3","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0168-8278(03)00396-9","article-title":"Prophylaxis with anti-HBs immune globulins and nuecleoside analogues after liver transplantation for HBV infection","volume":"39","author":"Villamil","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.transproceed.2010.05.127_bib4","first-page":"1","article-title":"AASLD Practice Guidelines","volume":"50","author":"Lok","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2010.05.127_bib5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jhep.2008.10.001","article-title":"EASL Clinical Practice Guidelines: management of chronic hepatitis B","volume":"50","year":"2009","journal-title":"J Hepatol"},{"issue":"suppl 4","key":"10.1016\/j.transproceed.2010.05.127_bib6","first-page":"496A","article-title":"Entecavir and tenofvir combination therapy in chronic hepatitis B: rescue therapy in patients with advanced fibrosis and multiple previous treatment failures","volume":"50","author":"Petersen","year":"2009","journal-title":"Hepatology"},{"issue":"suppl 4","key":"10.1016\/j.transproceed.2010.05.127_bib7","first-page":"505A","article-title":"Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with evidence of hepatic decompensation","volume":"50","author":"Liaw","year":"2009","journal-title":"Hepatology"},{"issue":"suppl 4","key":"10.1016\/j.transproceed.2010.05.127_bib8","first-page":"409A","article-title":"Interim results of a double-blind, randomized phase 2 study of the safety of tenefovir disoproxil fumurate, emtricitabine plus tenofovir disoproxil fumarate and entecavir in the treatment of chronic hepatitis B subjects with decompensated liver disease","volume":"50","author":"Liaw","year":"2009","journal-title":"Hepatology"},{"issue":"suppl 1","key":"10.1016\/j.transproceed.2010.05.127_bib9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0168-8278(09)60903-X","article-title":"Efficacy of combination of entecavir and tenofovir treatment in hepatitis B related decompensated chronic liver disease: pilot study","volume":"50","author":"Amarapurkar","year":"2009","journal-title":"J Hepatol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004113451000792X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004113451000792X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T08:52:03Z","timestamp":1544172723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004113451000792X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":9,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S004113451000792X"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2010.05.127","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}